Ming-Feng Zhang

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Y. Hu, Ying Cheng, Yi-long Wu, 2020, Frontiers in Oncology.

Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?

Chongrui Xu, Yi-chen Zhang, Qing Zhou, 2017, Expert review of molecular diagnostics.

EGFR mutations in early‐stage and advanced‐stage lung adenocarcinoma: Analysis based on large‐scale data from China

Xing Gao, Chongrui Xu, Hong-Hong Yan, 2018, Thoracic cancer.

The spatiotemporal evolution of EGFR C797S mutation in EGFR-mutant non-small cell lung cancer: opportunities for third-generation EGFR inhibitors re-challenge.

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2019, Science bulletin.